Aptus Pharma Limited is engaged in the business of marketing and distribution of finished pharmaceutical formulations. The company provides a wide range of products covering multiple therapeutic areas including antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more.
The company has structured its portfolio into four key divisions for focused growth and market penetration:
- Aptus Pharma (Pioneer Division): Specialises in acute therapies such as anti-infectives, pain management, and gastrointestinal drugs.
- Aptus CD Care: Focused on chronic therapies including cardiovascular and anti-diabetic products.
- Aptus Wellcare: Offers nutraceuticals, wellness solutions, OTC products, and personal care.
- Aptus Global: Dedicated to exports in overseas markets.
As of March 31, 2025, Aptus Pharma had 194 pharmaceutical formulations spanning across more than 11 therapeutic segments.
The company operates through a warehousing network covering 15,732 sq. ft. and 1,989 sq. ft. in Ahmedabad, Gujarat. Its distribution model includes 125 direct and sub-distributors, supported by a sales team of 54 field personnel, ensuring wide market coverage and reach.
As of March 31, 2025, Aptus Pharma employed 70 people, covering functions across sales, distribution, operations, and management.
Aptus Pharma IPO – Details
| IPO Opening Date | 23 September 2025 |
| IPO Closing Date | 25 September 2025 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Total Issue: 18,60,000 Shares Worth ₹13.02 Crore Fresh Issue: 18,60,000 Shares Worth ₹13.02 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹65– ₹70 per share |
| Market Lot | 2000 Shares |
| Min Order | 2000 Shares [ 1 Lot ] |
| Listing At | BSE SME |
| Registrar | Bigshare Services Pvt.Ltd. |
| QIB Shares Offered | 50% |
| NII Shares Offered | 15% |
| Retail Shares Offered | 35% |
Aptus Pharma IPO – Date Schedule
| IPO Open Date | 23 September 2025 |
| IPO Close Date | 25 September 2025 |
| Basis of Allotment | 26 September 2025 |
| Initiation of Refund | 29 September 2025 |
| Credit of Shares to Demat | 29 September 2025 |
| IPO Listing Date | 30 September 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on September 25, 2025 |
Aptus Pharma IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 4,000 | ₹2,80,000 |
| Retail (Max) | 2 | 4,000 | ₹2,80,000 |
| S-HNI (Min) | 3 | 6,000 | ₹4,20,000 |
| S-HNI (Max) | 7 | 14,000 | ₹9,80,000 |
| B-HNI (Min) | 8 | 16,000 | ₹11,20,000 |
Competitive Strengths
- Diversified product portfolio.
- Robust distribution network.
- Strategic manufacturing alliances across Gujarat, Uttarakhand and Himachal Pradesh.
- Competitive and cost-effective pricing.
- Experienced management team.
Company Promoters
- Tejash Maheshchandra Hathi
- Chatrabhuj Vallabhbhai Butani
- Kapilbhai Hasmukhbhai Chandarana
- Ghanshyam Vinubhai Pansuriya
- Milly Chetan Lalseta
- Riddhish Natwarlal Tanna
- Gaurang Rameshchandra Thakker
- Kripaliben Mayank Thakker
- Kunjal Piyushbhai Unadkat
Company Financials
| Period | Total Revenue | Total Expense | Profit After Tax | Total Borrowings |
|---|---|---|---|---|
| 31 March 2023 | ₹13.90 Cr | ₹13.60 Cr | ₹0.19 Cr | ₹2.21 Cr |
| 31 March 2024 | ₹17.88 Cr | ₹16.76 Cr | ₹0.80 Cr | ₹5.31 Cr |
| 31 March 2025 | ₹24.64 Cr | ₹20.44 Cr | ₹3.10 Cr | ₹10.36 Cr |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 44.50% |
| ROCE | 45.66% |
| Debt/Equity | 1.49 |
| RoNW | 44.50% |
| EBITDA Margin | 19.31% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 6.20 | 4.52 |
| P/E (x) | 11.29 | 15.49 |
Object Of The Issue
| Objects of the Issue | Expected Amount (in Crore) |
|---|---|
| Capital Expenditure for Office Premises with furniture and Industrial Racks. | ₹1.63 |
| Working Capital | ₹8.00 |
| General Corporate Purposes. | – |
✅Strengths
- Wide portfolio of 194 formulations across 11+ therapeutic areas.
- Four focused divisions (acute, chronic, wellness, exports).
- Asset-light contract manufacturing model with seven units.
- Strong distribution (125 distributors, 54 sales staff).
- Growing overseas presence and experienced management.
⚠️Risks
- Dependence on third-party manufacturers.
- Intense competition in pharma sector.
- Regulatory and compliance challenges.
- Working capital–heavy operations.
- Pending trademark updates post conversion.
Aptus Pharma IPO Promoter Holding
| Pre Issue Share Holding | 100.00% |
| Post Issue Share Holding | 72.89% |
Aptus Pharma IPO Prospectus
Company Contact Information
| Aptus Pharma Ltd. Ashutosh Buildcon, Opp. Slok – 2, Nr. Harikrupa Logistic Park, Aslali, Ahmedabad, Daskroi, Ahmedabad, Gujarat, 382427 Phone: +91 76004 27827 Email: info@aptuspharma.com Website: https://aptus-pharma.com/ |
Aptus Pharma IPO Registrar
| Bigshare Services Pvt.Ltd. Phone: +91-22-6263 8200 Email: ipo@bigshareonline.com Website: https://ipo.bigshareonline.com/IPO_Status.html |
Aptus Pharma IPO Lead Manager(s)
| 1. Interactive Financial Services Ltd. |
Aptus Pharma IPO FAQ
| What is Aptus Pharma IPO? Aptus Pharma IPO is an SME IPO. The issue is priced at ₹65 – ₹70 per equity share. The IPO is to be listed on BSE SME. |
| When Aptus Pharma IPO will open? The IPO is to open on 23 September 2025 for QIB, NII, and Retail Investors. |
| What is Aptus Pharma IPO Investors Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| What is the Aptus Pharma IPO Size? Aptus Pharma IPO size is ₹13.02 Crore. |
| What is Aptus Pharma IPO Minimum and Maximum Lot Size for Retail? The minimum bid is 4000 Shares with ₹2,80,000 amount, while the maximum bid is 4000 Shares with ₹2,80,000. |
| What is the Aptus Pharma IPO Allotment Date? Aptus Pharma IPO allotment date is 26 September 2025. |
| What is the Aptus Pharma IPO Listing Date? Aptus Pharma IPO listing date is 30 September 2025. The IPO is to be listed on the BSE SME. |
